AdaptHealth Corp. (AHCO)10% owner bought ~$6.71M
OEP VII GP, 10% owner at AdaptHealth Corp., bought ~$6.71M of AdaptHealth Corp. shares.
- ~$6.71M
- Approx. value · 689K sh @ $9.73
- 15.9M
- Holds after · shares reported
- Traded
- Mar 12, 2026
- Filed
- Mar 30, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Feb 24, 2026Company filing · Form 8-K · ResultsReported its results
- Feb 26, 2026Insider · First insider buy since Aug 2023Officer purchased ~$45K of AHCO shares in the open market
- Feb 27, 2026Insider · First buy since 2021Director purchased ~$72K of AHCO shares in the open market
- Mar 10, 2026Insider · 2 peopleInsiders: 2 purchases (~$16.0M)
- Mar 11, 2026Insider · 2 peopleInsiders: 2 purchases (~$10.4M)
- Mar 12, 2026 · this disclosureInsider10% owner purchased ~$6.71M of AHCO shares in the open market
What came next
- Mar 12, 2026Insider10% owner purchased ~$6.71M of AHCO shares in the open market
- Mar 19, 2026Insider · 2 peopleInsiders: 2 purchases (~$14K)
- Mar 20, 2026Insider · 2 peopleInsiders: 2 purchases (~$8.9M)
- Apr 10, 2026Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 2 more items)
- May 4, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On May 5, 2026, AdaptHealth Corp. (the “Company”) filed a Current Report on Form 8-K (the “Original Filing”) reporting, among other things, the appointment of Daniel McFadden as Chief Operating Officer of the Company, effective as of May 4, 2026 (the “Appointment Date”).”
- May 5, 2026Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results“On May 4, 2026, the Company terminated the employment of Toby Scott Barnhart, the Company’s Chief Operating Officer.”
- Jun 1, 2026InsiderOfficer sold ~$113K of AHCO shares in the open market
- Jun 27, 2026Company filing · Form 8-K · Cyber incidentReported a cybersecurity incident“AdaptHealth Corp. (the “Company”) is investigating a security incident whereby a threat actor gained unauthorized access to Company systems and exfiltrated certain data therefrom.”
- Jul 1, 2026InsiderOfficer sold ~$118K of AHCO shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for AdaptHealth Corp.
For AdaptHealth Corp., OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 3 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AHCO page.
Other recent filings by OEP VII GP, L.L.C., 10% owner
- SEC Form 4 at AdaptHealth Corp. (AHCO)Mar 30, 2026
- SEC Form 4 at AdaptHealth Corp. (AHCO)Mar 30, 2026
- SEC Form 4 at AdaptHealth Corp. (AHCO)Mar 30, 2026
- SEC Form 4 at AdaptHealth Corp. (AHCO)Mar 30, 2026
The full history of OEP VII GP, L.L.C., 10% owner is on the profile page.
How this filing works
Other disclosures at AdaptHealth Corp.
- SEC Form 4Aug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 12, 2026
- SEC Form 4Aug 11, 2026
- SEC Form 13F-HRJul 8, 2026
Everything OQRO holds on this company is on its AHCO page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
